Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD)

Clinical trial NCT04805411 · COMPLETED

Trial details

NCT number: NCT04805411
Sponsor: Keymed Biosciences Co.Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Moderate-to-severe Atopic Dermatitis

Start date: 2021-02-24
Primary completion: 2021-11-08
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.